dr. F. (Fariba) Ahmadizar

dr. F. (Fariba) Ahmadizar

Assistant Professor
dr. F. (Fariba) Ahmadizar
  • Julius Center, dept. Data Science & Biostatistics

Research Programs

Child Health




Family name, First name: Ahmadizar, Fariba Researcher unique identifier(s):

Nationality: Dutch

URL for website:

‪Fariba Ahmadizar‬ - ‪Google Scholar‬ Fariba_Ahmadizar





Ph.D. in Pharmacoepidemiology

Faculty of Science/ Clinical Pharmacology Department, Utrecht University, The Netherlands


MSc in Epidemiology

Julius Center, University Medical Center Utrecht, Utrecht, The Netherlands




2017- Present Visiting professor of Pharmacoepidemiology, Shiraz University of Medical Science, Iran

2021- Present Assistant Professor, Department of Data Science, University Medical Center Utrecht, The Netherlands



2017    Mining treatment in patients with type 2 diabetes, Main applicant.

2018    Medication treatment policy in patients with non-communicable disorders, Co-applicant.

2020    Stratification of Obese Phenotypes to Optimize Future Obesity Therapy (SOPHIA), IMI grant, Co- applicant.




2018 – Present 1 postdoc/ 7 Ph.D./ 10 MSc Department of Epidemiology, Erasmus Medical Center, The Netherlands; Department of Data Science, University Medical Center Utrecht, The Netherlands




Teaching assistant in Pharmacoepidemiology, NIHES, The Netherlands


Lecturer on Diabetes Epidemiology, NIHES, The Netherlands

2019- Present

Lecturer on systematic review and meta-analysis, Virtual education, LMiC-P4 program

2019- Present

Lecturer on study design, Virtual education, LMiC-P4 program




Lecturer on Molecular Pharmacoepidemiology, NIHES, The Netherlands



Lecturer on Genetic Epidemiology, NIHES, The Netherlands

2020- Present

Lecturer and academic advisor in EU2P: European education and training program in

pharmacovigilance and pharmacoepidemiology

2022                Lecturer in Advanced topics in causal research, MSc Epidemiology, UMC Utrecht, The Netherlands




Principal Investigator of the three big initiatives:

2019     Developing an academic post-graduate training for Low and Middle-Income Countries known as LMiC-P4; Pharmacoepidemiology & Pharmacovigilance, Pharmacogenetics, and Pharmacoeconomy

2020   Prediabetes trajectory of biomarkers in type 2 diabetes development (PARKER) Consortium 2020           International big databank directory (iBiD) Consortium

2021   Dutch Drug-induced Liver Injury (DiLi) initiative



2018-2019       Coordinating pre-conference courses at Euro-Asian Pharmacoepidemiology Congress (EAPEC)

2020-Present    International scientific coordinator at EAPEC



2017 – Present    Reviewer, Lancet, JAMA, Diabetes Medicine, European Journal of Preventive Cardiology, Frontiers, Global Heart, Diabetes, Metabolic Syndrome and Obesity, BMJ, EJPC

2018 – Present   Scientific Advisory Board, EAPEC

2020 – Present    Associate Editor, Frontiers in Pharmacology, Frontiers in Public health, Frontiers in Medicine, Frontiers in Endocrinology



2015-present    Member of International Society for Pharmacoepidemiology (ISPE) 2017-present             Member of the European Association for the Study of Diabetes (EASD) 2019-present             Member of Dutch Association for Diabetes Research

2020-2021        Board member Postdoc Network in the Netherlands



  • Steno Diabetes Center, Diabetes Epidemiology/Denmark
  • Institute of Social and Preventive Medicine (ISPM), University of Bern/ Switzerland
  • DiaGene, Erasmus Medical Center, The Netherlands
  • CHARGE Consortium diabetes working group
  • PARKER Consortium diabetes working group
  • BBMRI-NL Consortium diabetes working group
  • Combi-Bio Consortium diabetes working group
  • NCD-RisC Consortium
  • SOPHIA Consortium diabetes and obesity working groups



January2018-August 2018 Invited to develop a Pharmacoepidemiology group in the Iranian Ministry of Health



Research Output (22)

Safety of COVID-19 Vaccines Among the Paediatric Population:Analysis of the European Surveillance Systems and Pivotal Clinical Trials

Ahmadizar Fariba, Luxi Nicoletta, Raethke Monika, Schmikli Sandor, Riefolo Fabio, Saraswati Putri Widi, Bucsa Camelia, Osman Alhadi, Liddiard Megan, Maques Francisco Batel, Petrelli Giuliana, Sonderlichová Simona, Thurin Nicolas H, Villalobos Felipe, Trifirò Gianluca, Sturkenboom Miriam, 27 Apr 2023, In: Drug Safety. 46 , p. 575-585 11 p.

Trajectories of Cognition and Daily Functioning Before and After Incident Diabetes

Ji Xiaoli, Gao Hui, Sun Daoyuan, Zhuang Jianlin, Fang Yuan, Wang Kan, Ahmadizar Fariba 15 Nov 2022, In: Diabetes Care. 46 , p. 75-82 8 p.

Evaluation of the Factors Associated with Prescribed and Non-Prescribed Medicine:A Population-Based Study

Eskandari Mehrnoosh, Alizadeh Bahmani Amir Hossein, Hoorang Mehdi, Zare Marziyeh, Afifi Saba, Karimzadeh Iman, Azadi Soha, Sabzghabaee Ali Mohammad, Lankarani Kamran B, Ahmadizar Fariba, Peymani Payam 3 Nov 2022, In: Current Drug Safety. 18 , p. 528-533 6 p.

Respiratory syncytial virus vaccination during pregnancy for improving infant outcomes

Phijffer Emily, de Bruin Odette, Wildenbeest Joanne G., Bont Louis J., Sturkenboom Miriam C.J.M., Van der Maas Nicoline A.T., Ahmadizar Fariba, Bloemenkamp Kitty W.M. 21 Oct 2022, In: Cochrane Database of Systematic Reviews. 2022

Plasma circulating microRNAs associated with obesity, body fat distribution, and fat mass: the Rotterdam Study

Abozaid Yasir J., Zhang Xiaofang, Mens Michelle M. J., Ahmadizar Fariba, Limpens Marlou, Ikram M. Arfan, Rivadeneira Fernando, Voortman Trudy, Kavousi Maryam, Ghanbari Mohsen 10 Oct 2022, In: International Journal of Obesity. 46 , p. 2137-2144 8 p.

Association of baseline level of cardiovascular risk burden and its temporal changes with cognitive decline

Ji Xiaoli, Gao Hui, Sun Daoyuan, Zhao Wensui, Zhuang Jianlin, Wang Kan, Ahmadizar Fariba 1 Sep 2022, In: Frontiers in Aging Neuroscience. 14

Clusters of risk factors in metabolic syndrome and their influence on central blood pressure in a global study

Laucyte-Cibulskiene Agne, Chen Chen-Huan, Cockroft John, Cunha Pedro G., Kavousi Maryam, Laucevicius Aleksandras, Muiesan Maria Lorenza, Rietzschel Ernst R., Ryliskyte Ligita, Strazhesko Irina D., Vlachopoulos Charalambos, Cotter Jorge, Dudinskaya Ekatherina N., Gale Nichola, Ahmadizar Fariba, Mattace-Raso Francesco U. S., Munnery Maggie, Oliveira Pedro, Paini Anna, Salvetti Massimo, Tkacheva Olga N., Lakatta Edward G., Nilsson Peter M., Scuteri Angelo 24 Aug 2022, In: Scientific Reports. 12 , p. 14409

Prevalence of Fungal Drug Resistance in COVID-19 Infection: a Global Meta-analysis

Habibzadeh Adrina, Lankarani Kamran B., Farjam Mojtaba, Akbari Maryam, Kashani Seyyed Mohammad Amin, Karimimoghadam Zeinab, Wang Kan, Imanieh Mohammad Hossein, Tabrizi Reza, Ahmadizar Fariba 15 Aug 2022, In: Current fungal infection reports. 16 , p. 154-164 11 p.

The risk profile of patients with COVID-19 as predictors of lung lesions severity and mortality-Development and validation of a prediction model

Rahimi Ezat, Shahisavandi Mina, Royo Albert Cid, Azizi Mohammad, El Bouhaddani Said, Sigari Naseh, Sturkenboom Miriam, Ahmadizar Fariba 25 Jul 2022, In: Frontiers in Microbiology. 13

All research output

Thank you for your review!

Has this information helped you?

Please tell us why, so that we can improve our website.

Working at UMC Utrecht





Practical maakt gebruik van cookies

Deze website maakt gebruik van cookies Deze website toont video’s van o.a. YouTube. Dergelijke partijen plaatsen cookies (third party cookies). Als u deze cookies niet wilt kunt u dat hier aangeven. Wij plaatsen zelf ook cookies om onze site te verbeteren.

Lees meer over het cookiebeleid

Akkoord Nee, liever niet